You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pulmonary Fibrosis

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Completed
  • Idiopathic Pulmonary Fibrosis
  • Milton, Massachusetts
    Medicus Economics, LCC
Aug 8, 2022

Idiopathic Pulmonary Fibrosis Trial (ARO-MMP7 Inhalation Solution, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • ARO-MMP7 Inhalation Solution
  • Placebo
  • (no location specified)
Sep 8, 2022

Safety of Nintedanib in Real World in China

Not yet recruiting
  • Pulmonary Fibrosis
  • Beijing, China
    China-Japan Friendship Hospital
Jan 26, 2023

Cough, Asthma, COPD Trial (C-mo System)

Not yet recruiting
  • Cough
  • +4 more
  • C-mo System
  • (no location specified)
Aug 4, 2023

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19

Completed
  • Post-COVID-19 Syndrome
  • Lung Fibrosis
  • Corticosteroids alone
  • +3 more
  • Mansoura, Dakahlia, Egypt
    Mansoura University
Dec 11, 2022

Idiopathic Pulmonary Fibrosis Trial in Paris (18FDG-PET scan)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 18FDG-PET scan
  • Paris, France
    Service de Pneumologie A Centre constitutif de référence des mal
Oct 3, 2022

Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis, Asthma Trial in Seoul (HiCardi+)

Recruiting
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • HiCardi+
  • Seoul, Korea, Republic of
    Severance Hospital
May 8, 2023

Genentech Validation Tool for Pulmonary Fibrosis

Recruiting
  • Interstitial Lung Disease
    • New York, New York
      Columbia University Irving Medical Center
    Nov 4, 2022

    Lung Disease Associated With Rheumatoid Arthritis

    Completed
    • Pulmonary Fibrosis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 27, 2022

      Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • REGEND001 Autologous Therapy Product
      • Beijing, Beijing, China
      • +2 more
      Dec 19, 2022

      Idiopathic Pulmonary Fibrosis Trial in Shanghai (SC1011, Placebo tablet)

      Completed
      • Idiopathic Pulmonary Fibrosis
      • Shanghai, Shanghai, China
        Shanghai Xuhui District Central Hospital
      Nov 14, 2023

      Pulmonary Fibrosis, COVID-19 Respiratory Infection Trial in Liberty (EV-Pure™ and WJ-Pure™ plus standard care, Placebo)

      Recruiting
      • Pulmonary Fibrosis
      • COVID-19 Respiratory Infection
      • EV-Pure™ and WJ-Pure™ plus standard care
      • Placebo
      • Liberty, Missouri
        Kit Bartalos
      Oct 11, 2022

      All-Case Surveillance of Ofev in Patients With IPF in Japan

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Multiple Locations, Japan
        (unnamed)
      Jan 23, 2023

      Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux Trial in Tucson (Positive Airway Pressure)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • +2 more
      • Positive Airway Pressure
      • Tucson, Arizona
        University of Arizona
      Sep 15, 2022

      Idiopathic Pulmonary Fibrosis Trial in Paris (TLC1_TM6, TM6_TLC1)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • TLC1_TM6
      • TM6_TLC1
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Sep 30, 2022

      Idiopathic Pulmonary Fibrosis Trial (LTP001, Placebo, Standard of Care (SoC))

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • (no location specified)
      Aug 10, 2022

      Idiopathic Pulmonary Fibrosis Trial in Shanghai (Human umbilical cord mesenchymal stem cell injection)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Human umbilical cord mesenchymal stem cell injection
      • Shanghai, Shanghai, China
        Shanghai Sixth People's Hospital
      Jul 29, 2022

      Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,

      Enrolling by invitation
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease
      • Inhaled Treprostinil
      • Treprostinil Ultrasonic Nebulizer
      • Kissimmee, Florida
      • +2 more
      Jul 19, 2022

      Generalized Anxiety Disorder, Depression, Idiopathic Pulmonary Fibrosis Trial in San Francisco (digital cognitive behavioral

      Recruiting
      • Generalized Anxiety Disorder
      • Pulmonary Fibrosis
      • Digital cognitive behavioral therapy
      • San Francisco, California
      • +1 more
      Dec 13, 2022

      Idiopathic Pulmonary Fibrosis Trial in Birmingham (PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
      • Birmingham, Alabama
        The University of Alabama at Birmingham
      Jun 7, 2022

      Idiopathic Pulmonary Fibrosis Trial in Australia, New Zealand (Ifenprodil)

      Completed
      • Idiopathic Pulmonary Fibrosis
      • Brookvale, New South Wales, Australia
      • +5 more
      Jul 18, 2022

      End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Mechanical Ventilation Pressure High
        • Modena, Italy
          Azienda Ospedaliero Universitaria Policlinico di Modena
        May 16, 2022

        Idiopathic Pulmonary Fibrosis Trial in Durham (Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF)

        Recruiting
        • Idiopathic Pulmonary Fibrosis
        • Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment
        • Durham, North Carolina
          Duke University Medical Center
        May 3, 2022

        Idiopathic Pulmonary Fibrosis Trial in Dijon (FMISO-PET Protocol)

        Not yet recruiting
        • Idiopathic Pulmonary Fibrosis
        • FMISO-PET Protocol
        • Dijon, France
          Chu Dijon Bourgogne
        Jul 5, 2022

        Acute Exacerbation of Idiopathic Pulmonary Fibrosis Trial in France (Methylprednisone/Prednisone, Placebo)

        Not yet recruiting
        • Acute Exacerbation of Idiopathic Pulmonary Fibrosis
        • Angers, France
        • +28 more
        Jan 11, 2023